Results 1 to 10 of about 18,891 (189)

Gut microbiota dependant trimethylamine N-oxide and hypertension

open access: yesFrontiers in Physiology, 2023
The human gut microbiota environment is constantly changing and some specific changes influence the host’s metabolic, immune, and neuroendocrine functions. Emerging evidence of the gut microbiota’s role in the development of cardiovascular disease (CVD) including hypertension is remarkable.
Katongo H. Mutengo   +6 more
openaire   +4 more sources

Trimethylamine N-oxide in atrial fibrillation progression

open access: yesIJC Heart & Vasculature, 2020
The human gut microbiome and its metabolite Trimethylamine N-oxide (TMAO) are sensitive to the human diet and are involved in the complex pathomechanisms that underpin diabetes, obesity, and cardiovascular diseases. A potential involvement of increased TMAO in atrial fibrillation (AF) manifestation and progression is not clear.
Petra Büttner   +7 more
openaire   +4 more sources

Trimethylamine N-oxide—a marker for atherosclerotic vascular disease [PDF]

open access: yesReviews in Cardiovascular Medicine, 2021
As a potential causative factor in various cardiovascular diseases, the gut microbe-generated metabolite trimethylamine N-oxide (TMAO) has courted considerable research interest as a potential biomarker. TMAO is a small molecule considered to be beneficial for the health of deep-water animals due to its ability to protect proteins against hydrostatic ...
Guinan Xie   +4 more
openaire   +3 more sources

Role of Trimethylamine N-Oxide in Heart Failure

open access: yesReviews in Cardiovascular Medicine
Heart failure (HF) is a clinical syndrome characterizing by typical physical signs and symptomatology resulting from reduced cardiac output and/or intracardiac pressure at rest or under stress due to structural and/or functional abnormalities of the heart.
Lele Jing   +6 more
openaire   +4 more sources

Trimethylamine-N-oxide and cerebral stroke risk: A review

open access: yesNeurobiology of Disease
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced by the action of gut microbiota and the hepatic enzyme Flavin Mono‑oxygenase 3 (FMO3). TMAO level has a positive correlation with the risk of cardiovascular events, including stroke, and their level is influenced mainly by dietary choice and the action of liver enzyme FMO3 ...
Phurbu Dolkar   +13 more
openaire   +4 more sources

Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia

open access: yesAlzheimer's Research & Therapy
AbstractBackgroundThe gut-derived metabolite Trimethylamine N-oxide (TMAO) and its precursors - betaine, carnitine, choline, and deoxycarnitine – have been associated with an increased risk of cardiovascular disease, but their relation to cognition, neuroimaging markers, and dementia remains uncertain.MethodsIn the population-based Rotterdam Study, we ...
Yaqub, A   +10 more
openaire   +5 more sources

Atherosclerosis and trimethylamine-N-oxide — the gut microbiota potential

open access: yesРоссийский кардиологический журнал, 2022
Gut dysbiosis contribute to the development of atherosclerosis. Firmicutes contain a trimethylamine-producing gene cluster. The aim was to analyze potential role of trimethylamine-N-oxide (TMAO), gut microbiota metabolite, in the pathogenesis of ...
I. N. Grigorieva
doaj   +1 more source

Trimethylamine N-Oxide (TMAO) and Trimethylamine (TMA) Determinations of Two Hadal Amphipods

open access: yesJournal of Marine Science and Engineering, 2022
Hadal trenches are a unique habitat with high hydrostatic pressure, low temperature and scarce food supplies. Amphipods are the dominant scavenging metazoan species in this ecosystem.
Qi Liu   +4 more
doaj   +1 more source

Trimethylamine N-oxide in cardiovascular disease

open access: yesAdvances in Clinical and Experimental Medicine, 2022
Although traditional cardiovascular risk factors are well established and understood, mortality and morbidity in patients with cardiovascular disease (CVD) remains high. Exploring new pathophysiological pathways enables a better understanding of CVD at both the molecular and clinical levels.
Radoslaw Konieczny, Wiktor Kuliczkowski
openaire   +2 more sources

Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Trimethylamine‐N‐oxide (TMAO) is a small molecule derived from the metabolism of dietary nutrients by gut microbes and contributes to cardiovascular disease. Plasma TMAO increases following consumption of red meat.
Marc Ferrell   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy